Cargando…

ZMYM3 May Promote Cell Proliferation in Small Cell Lung Carcinoma

Zinc finger, myeloproliferative, and mental retardation-type containing 3 (ZMYM3) is a highly conserved protein among vertebrates. Although it promotes DNA repair and moderate histone acetylation, the other functions of ZMYM3 remain unclear. We herein examined the physiological functions of ZMYM3 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kudo, Noritaka, Kudoh, Shinji, Matsuo, Akira, Motooka, Yamato, Ito, Takaaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY 2021
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569135/ https://www.ncbi.nlm.nih.gov/pubmed/34764523 http://dx.doi.org/10.1267/ahc.21-00012

Ejemplares similares

Significance of Stat3 Signaling in Epithelial Cell Differentiation of Fetal Mouse Lungs
por: Kameyama, Hiroki, et al.
Publicado: (2017)

Expression of Draxin in Lung Carcinomas
por: Sato, Younosuke, et al.
Publicado: (2018)

Pulmonary Neuroendocrine Cells and Small Cell Lung Carcinoma: Immunohistochemical Study Focusing on Mechanisms of Neuroendocrine Differentiation
por: Ito, Takaaki, et al.
Publicado: (2022)

Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins
por: Cibis, Hannah, et al.
Publicado: (2020)

Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors
por: Sato, Younosuke, et al.
Publicado: (2020)

ZMYM2 inhibits NANOG-mediated reprogramming
por: Lawrence, Moyra, et al.
Publicado: (2019)

Notch1 controls cell chemoresistance in small cell lung carcinoma cells
por: Hassan, Wael Abdo, et al.
Publicado: (2015)

ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair
por: Leung, Justin W.C., et al.
Publicado: (2017)

ZMYM3: a new candidate gene in nonobstructive azoospermia?
por: Beulze, Morgane Le, et al.
Publicado: (2023)

Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
por: Kawahara, M, et al.
Publicado: (2001)

The Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation
por: Lezmi, Elyad, et al.
Publicado: (2020)

Zmym4 is required for early cranial gene expression and craniofacial cartilage formation
por: Jourdeuil, Karyn, et al.
Publicado: (2023)

ZMYM2 is essential for methylation of germline genes and active transposons in embryonic development
por: Graham-Paquin, Adda-Lee, et al.
Publicado: (2023)

Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer
por: Takeda, K, et al.
Publicado: (1999)

UBE2B promotes ovarian cancer growth via promoting RAD18 mediated ZMYM2 monoubiquitination and stabilization
por: Zeng, Xi, et al.
Publicado: (2022)

hTERT promoter methylation promotes small cell lung cancer progression and radiotherapy resistance
por: Zhai, Guangsheng, et al.
Publicado: (2020)

Periostin is a negative prognostic factor and promotes cancer cell proliferation in non-small cell lung cancer
por: Okazaki, Toshimasa, et al.
Publicado: (2018)

ZMYM2 controls human transposable element transcription through distinct co-regulatory complexes
por: Owen, Danielle J, et al.
Publicado: (2023)

Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer
por: Coulson, J M, et al.
Publicado: (1999)

Identification of nuclear phosphoproteins as novel tobacco markers in mouse lung tissue following short-term exposure to tobacco smoke
por: Niimori-Kita, Kanako, et al.
Publicado: (2014)

Gene knockout of Zmym3 in mice arrests spermatogenesis at meiotic metaphase with defects in spindle assembly checkpoint
por: Hu, Xiangjing, et al.
Publicado: (2017)

Evolving evidence on a link between the ZMYM3 exceptionally long GA-STR and human cognition
por: Afshar, H., et al.
Publicado: (2020)

Somatostatin receptor staining in FFPE sections using a ligand derivative dye as an alternative to immunostaining
por: Hasegawa, Koki, et al.
Publicado: (2017)

Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome
por: Mishina, T, et al.
Publicado: (1999)

Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia
por: Jawhar, Mohamad, et al.
Publicado: (2017)

Intratracheal Administration of Recombinant Human Keratinocyte Growth Factor Promotes Alveolar Epithelial Cell Proliferation during Compensatory Lung Growth in Rat
por: Furukawa, Katsuro, et al.
Publicado: (2013)

Phase II study of compensator-based non-coplanar intensity-modulated radiotherapy for Stage I non–small-cell lung cancer
por: Itonaga, Tomohiro, et al.
Publicado: (2019)

NME4 may enhance non-small cell lung cancer progression by overcoming cell cycle arrest and promoting cellular proliferation
por: Wang, Wenqian, et al.
Publicado: (2019)

Glucocorticoid receptor over-expression promotes human small cell lung cancer apoptosis in vivo and thereby slows tumor growth
por: Sommer, Paula, et al.
Publicado: (2010)

Small-cell Lung Cancer Presenting as Fatal Pulmonary Hemorrhage
por: Lim, Jun Hyeok, et al.
Publicado: (2018)

ZMYM2 restricts 53BP1 at DNA double-strand breaks to favor BRCA1 loading and homologous recombination
por: Lee, Doohyung, et al.
Publicado: (2022)

Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

CD44 promotes cell proliferation in non-small cell lung cancer
por: Hu, Bo, et al.
Publicado: (2018)

CCDC106 promotes non-small cell lung cancer cell proliferation
por: Zhang, Xiupeng, et al.
Publicado: (2017)

FIGNL1 promotes non-small cell lung cancer cell proliferation
por: Li, Miao, et al.
Publicado: (2020)

BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression
por: Shen, Hongjie, et al.
Publicado: (2014)

Myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations
por: Chen, Dong, et al.
Publicado: (2023)

Serum p53 antibodies: predictors of survival in small-cell lung cancer?
por: Murray, P V, et al.
Publicado: (2000)

Chromogranin A, a significant prognostic factor in small cell lung cancer
por: Drivsholm, L, et al.
Publicado: (1999)

Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride
por: Kimura, Tatsuo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d2c1ap8t0sv3cl4s9gm6no9crf